Cargando…
Breast Cancer Recurrence Risk Assessment: Is Non-Invasive Monitoring an Option?
BACKGROUND: Metastatic breast cancer (MBC) represents a life-threatening disease with a median survival time of 18–24 months that often can only be treated palliatively. The majority of women suffering from MBC are those who had been previously diagnosed with locally advanced disease and subsequentl...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945973/ https://www.ncbi.nlm.nih.gov/pubmed/31988964 http://dx.doi.org/10.1159/000492929 |